Results 171 to 180 of about 301,296 (304)

Cumulative Incidence of Venous Thromboembolism in Patients With Uterine Cancer. [PDF]

O G Open
Sassine D, Chen L, Xu X, Ferris JS, Hershman DL, Wright JD, Hou JY.   +6 more
europepmc   +1 more source

Warm autoimmune haemolytic anaemia in Taiwan: A population‐based study of epidemiology, treatment patterns, survival and healthcare utilisation (2017–2022)

British Journal of Haematology, EarlyView.
Summary To describe the epidemiology, treatment patterns, overall survival (OS) and healthcare resource use among patients with warm autoimmune haemolytic anaemia (wAIHA) in Taiwan, adult patients with ≥1 diagnosis code for autoimmune haemolytic anaemia (AIHA) with record of wAIHA‐related treatments between 2017 and 2022 were retrospectively identified
Hsiao‐Wen Kao, Shu‐Chen Chang, Dae Young Yu, Tse‐Chih Chou, I‐Ching Tsai, Ann Leon, Alexis Krumme, David Bin‐Chia Wu, Chee Jen Chang   +8 more
wiley   +1 more source

Patterns of presentation of suspected and confirmed recurrent venous thromboembolism in patients with prior venous thromboembolism. [PDF]

Res Pract Thromb Haemost
Mai V, Martens ESL, Righini M, Schulman S, Thiruganasambandamoorthy V, Bates V, Pecarskie A, Kovacs MJ, Visser S, Shivakumar S, Tan M, Rodger M, Scarvelis D, Delluc A, Girard P, Huisman MV, Wells PS, Klok FA, Le Gal G, Kahn SR, PREDICTORS study group.   +20 more
europepmc   +1 more source

Estimated pulse wave velocity as a marker of major adverse cardiovascular events in essential thrombocythaemia and polycythaemia vera

British Journal of Haematology, EarlyView.
In patients with essential thrombocythaemia or polycythaemia vera, higher estimated pulse wave velocity (ePWV) was independently associated with major adverse cardiovascular events, while its relationship with overall survival was largely age‐driven.
Alessandro Costa, Olga Mulas, Federica Pilo, Eleonora Atzeni, Martina Pettinau, Daniela Mantovani, Giovanni Caocci   +6 more
wiley   +1 more source

Venous Thromboembolism in Severe Renal Insufficiency: 20 Years of Contemporary Management and Clinical Outcomes. [PDF]

JACC Adv
Sigüenza P, López-Núñez JJ, Hernández-Blasco L, Peris ML, Gómez-Cuervo C, Ferreiro-Celeiro J, Gómez-Mesa JE, Jiménez D, Bikdeli B, Monreal M, RIETE Investigators.   +10 more
europepmc   +1 more source

Phase 3, randomised, placebo‐controlled trial of voxelotor for the resolution of leg ulcers in sickle cell disease: RESOLVE

British Journal of Haematology, EarlyView.
In this trial, conducted in Kenya, Nigeria and Brazil, the resolution of leg ulcers was similar between the voxelotor and placebo arms. In the 12‐week blinded period, the number of sickle cell anaemia with crisis events was higher in the voxelotor arm compared to placebo.
Bernhards Ogutu, Janet Oyieko, Halima Bello‐Manga, Adeseye Akinsete, Jessie Githanga, José Valber Lima Meneses, Carolyn Hoppe, Mark W. Davis, Jeremy Rupon, Ching‐Ray Yu, Roberto Pinto, Elena Tudone, Ibrahim Musa Idris, Martin Meremikwu, Aderson da Silva Araújo, Rodolfo D. Cançado, Guilherme Fonseca, Patrícia Santos Resende Cardoso, Obiageli Eunice Nnodu, on behalf of the RESOLVE Investigators   +19 more
wiley   +1 more source

Venous thromboembolism is not associated with plasmin(ogen): reevaluating plasmin and mechanisms that degrade fibrin. [PDF]

Blood Adv
Sang Y, Shapiro AD, Wolberg AS.
europepmc   +1 more source

Prevention of Venous Thromboembolism in Patients with Ovarian Cancer: The State of the Research. [PDF]

Int J Womens Health
Tavares V, Medeiros R.
europepmc   +1 more source

International Delphi consensus on feminising genital surgery in assigned‐male‐at‐birth individuals

BJU International, EarlyView.
Objective To achieve an international expert consensus among surgeons on the indications, contraindications, and perioperative management of feminising genital surgery (FGS) for assigned‐male‐at‐birth (AMAB) individuals, using a Delphi process. Methods A two‐round on‐line Delphi survey (May–July 2025) followed by a final consensus meeting (September ...
Marta Pezzoli, Mattia Lo Re, Valeria Pizziconi, Marco Falcone, Mirko Preto, Marco Capece, Michele Rizzo, Guglielmo Mantica, Francesco Chierigo, Malte Vetterlein, Patrizio Vicini, François‐Xavier Madec, Paul Neuville, Wai Gin (Don) Lee, Francesca Vedovo, Saskia Morgenstern, Marjan Waterloos, Miroslav Djordjevic, Wesley Verla, Lukasz Bialek, Juan Diego Tinajero, Jordán Scherñuk, Tim Ludwig, Silke Riechardt, Lisa Szyper, Maren Wenk, Jochen Heß, Julia Bohr, Andrea Minervini, Andrea Cocci, on behalf of the Italian Society of Urodynamics (SIUD)   +30 more
wiley   +1 more source

Renal‐vascular axis: unmasking its role in vascular endothelial growth factor‐inhibitor vascular toxicity in cancer patients

British Journal of Pharmacology, EarlyView.
Abstract Vascular toxicity is a growing concern in cancer patients receiving vascular endothelial growth factor inhibitor (VEGFi) therapy, posing a significant threat to patient prognosis. While the primary mechanism of VEGFi‐induced vascular toxicity is linked to redox‐sensitive reactions that disrupt vascular tone, leading to hypertension and ...
Grace Whelan, Karla B. Neves
wiley   +1 more source